Contract

Provision of reagents for GridION platforms to support COG-UK

  • Public Health England

F03: Contract award notice

Notice identifier: 2021/S 000-007163

Procurement identifier (OCID): ocds-h6vhtk-02a36c

Published 7 April 2021, 10:56pm



Section one: Contracting authority

one.1) Name and addresses

Public Health England

Manor Farm Road, Porton Down

Salisbury

SP2 0QT

Email

Aysel.Sarzosa@phe.gov.uk

Telephone

+44 2076548000

Country

United Kingdom

NUTS code

UK - UNITED KINGDOM

Internet address(es)

Main address

https://www.gov.uk/government/organisations/public-health-england

one.4) Type of the contracting authority

Ministry or any other national or federal authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Provision of reagents for GridION platforms to support COG-UK

two.1.2) Main CPV code

  • 33696300 - Chemical reagents

two.1.3) Type of contract

Supplies

two.1.4) Short description

Public Health England (PHE) has awarded a contract to New England Biolabs UK Ltd for the provision of reagents to be used on GridION platforms urgently needed to support the COVID-19 Genomics UK (COG-UK) consortium work.

PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak.

two.1.6) Information about lots

This contract is divided into lots: No

two.1.7) Total value of the procurement (excluding VAT)

Value excluding VAT: £264,000

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - UNITED KINGDOM

two.2.4) Description of the procurement

This single tender action request is for the purpose of procuring reagents to be used on GridION platforms needed to support the COVID-19 Genomics UK (COG-UK) consortium work.

two.2.5) Award criteria

Price

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Award of a contract without prior publication of a call for competition in the cases listed below

  • Extreme urgency brought about by events unforeseeable for the contracting authority

Explanation:

The UK Government must protect the health and wellbeing of UK citizens. The COVID-19 outbreak is a Public Health Emergency of International Concern (PHEIC) as declared by the World Health Organisation on 30 January 2020. The WHO Director General characterised COVID-19 as a pandemic on 11 March 2020.

PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health and Social Care within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak.

The negotiated procedure without a prior publication has been used due to extreme urgency on the grounds of regulation 32(2)(c). This requirement is provided at short notice to support reduced testing turnaround times which are critical in the current outbreak and increased coronavirus testing capacity using an approved assay.

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section five. Award of contract

A contract/lot is awarded: Yes

five.2) Award of contract

five.2.1) Date of conclusion of the contract

15 January 2021

five.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor

New England Biolabs UK Ltd

Hertfordshire

Country

United Kingdom

NUTS code
  • UK - UNITED KINGDOM
The contractor is an SME

Yes

five.2.4) Information on value of contract/lot (excluding VAT)

Total value of the contract/lot: £264,000


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

Public Health England

London

Country

United Kingdom